Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CRO
CRO
Charles River lays off 70 staffers as strategic shift begins
The CRO is shifting research model production out of Wilmington, Massachusetts, as it looks to stanch steadily bleeding revenue.
Darren Incorvaia
Nov 14, 2025 4:40pm
BMS boosts cancer trials with Sarah Cannon's platform
Nov 12, 2025 12:30pm
Charles River to cut costs, shift direction as revenue slides
Nov 5, 2025 12:54pm
Thermo Fisher to buy Clario in $9B deal
Oct 31, 2025 12:41pm
Roche's Flatiron Health debuts 6 new blood cancer data sets
Oct 29, 2025 9:00am
Lilly, Nvidia team up to build industry-leading supercomputer
Oct 28, 2025 3:26pm